시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 심방세동 시장 규모, 점유율, 성장 분석 : 치료 유형별, 최종 용도별, 지역별 - 산업 예측(2025-2032년)
Atrial Fibrillation Market Size, Share, and Growth Analysis, By Treatment type (Pharmacological Treatment, Non-Pharmacological Treatment), By End-Use (Hospitals, Specialty Clinics), By Region - Industry Forecast 2025-2032
상품코드 : 1681646
리서치사 : SkyQuest
발행일 : 2025년 03월
페이지 정보 : 영문 219 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,868,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 9,205,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,541,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

심방세동 시장 규모는 2023년 233억 1,000만 달러로 평가되었습니다. 또한, 2024년 258억 5,000만 달러에서 2032년에는 591억 5,000만 달러로 성장하고, 예측 기간(2025-2032) 동안 10.9%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다.

심방세동 시장은 특히 고령화 사회에서의 유병률 증가와 카테터 절제술과 같은 치료기술의 발전으로 인해 큰 성장을 이루고 있습니다. 현재 미국에서는 65세 미만의 약 2%, 65세 이상의 약 9%가 심방세동으로 진단받고 있으며, 2050년에는 미국에서 600만-1,600만 명, 유럽에서는 2060년까지 900만-1,400만 명으로 급증할 것으로 예측되고 있습니다. 그러나 전문의 부족과 치료비 폭등 등 시장의 과제는 여전히 남아 있습니다. 레이저와 고주파의 응용 등 새로운 치료법의 통합은 도전이자 기회입니다. 또한, 약과 기기의 시너지 효과로 치료 성적이 향상되어 시장의 추가 확대가 기대됩니다.

목차

서론

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

심방세동 시장 규모 : 치료 유형별&CAGR(2025-2032년)

심방세동 시장 규모 : 최종 용도별&CAGR(2025-2032년)

심방세동 시장 규모&CAGR(2025-2032년)

경쟁 정보

주요 기업 개요

결론과 제안

LSH
영문 목차

영문목차

Atrial Fibrillation Market size was valued at USD 23.31 billion in 2023 and is poised to grow from USD 25.85 billion in 2024 to USD 59.15 billion by 2032, growing at a CAGR of 10.9% during the forecast period (2025-2032).

The atrial fibrillation (AFib) market is witnessing significant growth, driven by rising incidence rates, particularly among the aging population, and advancements in treatment technologies like catheter ablation. Currently, about 2% of individuals under 65 and nearly 9% of those over 65 in the U.S. are diagnosed with AFib, with projections indicating that cases could soar to between 6-16 million by 2050 in the U.S. and from 9 million to 14 million in Europe by 2060. However, market challenges, including a shortage of specialists and the high costs of treatment, persist. The integration of novel therapies, such as laser and radiofrequency applications, poses both a challenge and opportunity, as do synergies between medications and devices that could enhance management outcomes and stimulate further market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Atrial Fibrillation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Atrial Fibrillation Market Segments Analysis

Global Atrial Fibrillation Market is segmented by Treatment type, End-Use and region. Based on Treatment type, the market is segmented into Pharmacological Treatment and Non-Pharmacological Treatment. Based on End-Use, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Atrial Fibrillation Market

The atrial fibrillation market is primarily driven by the increasing aging population, which is particularly susceptible to this condition. According to the World Health Organization (WHO), by 2030, roughly one in six people worldwide will be aged 60 or older, indicating a significant demographic shift. The number of individuals in this age group is projected to grow from 1 billion in 2020 to 1.4 billion in 2030, and by 2050, it is expected to reach 2.1 billion. Moreover, there will be a substantial rise in the population aged 80 and above, with estimates suggesting a threefold increase to 426 million by 2050. This demographic trend highlights the urgent need for effective treatments and management strategies for atrial fibrillation as the population ages.

Restraints in the Atrial Fibrillation Market

The substantial expenses associated with treating atrial fibrillation represent a significant obstacle to the advancement of the atrial fibrillation market. According to research from Science Direction, the average hospitalization cost per patient is approximately USD 3,530 (with a 95% confidence interval of $3,328 to $3,732), while outpatient facility visits average around USD 3,878 (with a 95% confidence interval of $3,769 to $3,987). Additionally, emergency room visits incur an average charge of $394 (with a 95% confidence interval of $358 to $430). These high treatment costs are likely to impede the growth of the atrial fibrillation market significantly.

Market Trends of the Atrial Fibrillation Market

The atrial fibrillation (AFib) market is witnessing significant growth driven by the rising prevalence of the condition, which currently affects approximately 37.57 million individuals worldwide. The National Institutes of Health reports a 33% increase in incidence over the past two decades, highlighting a concerning trend, particularly in countries with middle socio-demographic indices. Modern lifestyle factors, including obesity, hypertension, and diabetes, are exacerbating the situation, further contributing to the market's expansion. As healthcare systems adapt to manage this growing demand, the AFib market is poised for innovation, with an increase in treatment options, diagnostic tools, and patient management solutions emerging as key trends.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Atrial Fibrillation Market Size by Treatment type & CAGR (2025-2032)

Global Atrial Fibrillation Market Size by End-Use & CAGR (2025-2032)

Global Atrial Fibrillation Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기